PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Spaulding Clinical Research, LLC

Press Release


Receive press releases from Spaulding Clinical Research, LLC: By Email RSS Feeds:

Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at DIA 2016


Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors is going to be exhibited at the Drug Informatoin Association's (DIA) 2016 conference.

West Bend, WI, June 25, 2016 --(PR.com)-- Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced that the Spaulding Electrocardiograph 2100iQ™ is to be exhibited at the Drug Information Association’s (DIA) 2016 conference.

The Spaulding 12-Lead ECG product line was originally launched in 2011 and is now in use in over 35 countries. The Spaulding Electrocardiograph 2100iQ has been optimized to visualize collected real-time digital ECG data via Bluetooth® using iOS™ 7+, Android™ 4.2+ and Windows™ 7+ devices. Data is wirelessly uploaded to the Spaulding webECG™ management cloud for Cardiologist over-reads and is designed to integrate with electronic medical records and clinical information management systems.

Features:

-Small (3.5 in), Lightweight (3.3 oz) Design for Easy Storage and Reduced Shipping Costs
-Single Button Operation for Ease of Use
-Protocol-Driven User Interface
-Multiple Protocol Support to Eliminate Need of Additional Equipment
-Stores up to 5 minutes of ECG data, Eliminates Need for Triplicate ECGs

“The Spaulding Electrocardiograph 2100iQ makes it logistically and financially feasible to collect very high-quality, centralized ECG data,” said Dr. Jay Mason, Chief Medical Officer. “This innovation in cardiac safety sets a new standard for data collection and gives Pharmaceutical Sponsors the ability to make earlier and better-informed drug development decisions.”

About Spaulding Clinical Research, LLC

Spaulding Clinical Research, LLC is a global CRO providing Phase I - IV drug development services to the biotechnology and pharmaceutical industries. Spaulding Clinical Research operates a 200-bed Clinical Pharmacology Unit, Cardiac Core Laboratory and provides full Biometrics/Scientific Affairs services.
Contact Information
Spaulding Clinical Research, LLC
Tyler Borst
(262) 334-6020
Contact
http://www.spauldingclinical.com

Click here to view the list of recent Press Releases from Spaulding Clinical Research, LLC
Promote Your Business